Fundraising FoxClub degli Investitori — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
A biosciences company combining targeted diagnostics and therapeutic delivery to improve outcomes in oncology.
BiotechDeep TechHealthtechMedical Devices
Alex Agnoletto(CEO, Co-Founder & Board Member)in
Co-investorsNovaCapitalFifth WallRedpoint VenturesRibbit CapitalSBI Mutual Fund
Lever Bio develops immunotherapy drug candidates in immuno-oncology, partnering with top researchers and academic institutions to translate discoveries into cancer immunotherapies.
BiotechDeep TechHealthtechMedical Devices
Pietro Puglisi(Chief Executive Officer)in
Co-investorsClaris VenturesExor VenturesItalian Angels for GrowthOra Global
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.